Skip to Content


In the US, Dulaglutide (dulaglutide systemic) is a member of the drug class incretin mimetics and is used to treat Diabetes, Type 2.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antidiabetic agent: Incretin-mimetic, glucagon-like peptide-1 (GLP-1) agonist

Chemical Name

Glucagon-like peptide-1-immunoglobulin G4 fusion protein, [2-glycyl,16-L-glutamyl,30-glycyl][human glucagon-like peptide 1-(7-37)-peptide]{(8-A>G,22-G>E,36-R>G)-GLP-1(7-37)} fusion protein with tris(tetraglycyl-L-seryl)-L-alanine (linker) fusion protein w (WHO)

Foreign Names

  • Dulaglutidum (Latin)
  • Dulaglutid (German)
  • Dulaglutide (French)
  • Dulaglutida (Spanish)

Generic Names

Brand Names

  • Trulicity
    Eli Lilly, Switzerland; Eli Lilly, Croatia (Hrvatska); Eli Lilly and Company, United Kingdom; Eli Lilly and Company, United States; Lilly, Germany; Lilly, France


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.